Antioxidant, Antibacterial Properties of Novel Peptide CP by Enzymatic Hydrolysis of Chromis notata By-Products and Its Efficacy on Atopic Dermatitis
Marine Drugs · 12.01.2024 · 22 (1) · 44
DOI: 10.3390/md22010044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 12.01.2024. Verfasst von Jin-Woo Hwang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Science, College of Health Science, Dankook University, Cheonan-si 31116, Chungcheongnam-do, Republic of Korea. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Perciformes, Sulfonic Acids, Benzothiazoles. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Oceans and Fisheries, Ministry of Oceans and Fisheries, Korea.
Abstract (Originalsprache)
This study investigated the antioxidant, antimicrobial, and anti-atopic dermatitis (AD) effects of a novel peptide (CP) derived from a Chromis notata by-product hydrolysate. Alcalase, Flavourzyme, Neutrase, and Protamex enzymes were used to hydrolyze the C. notata by-product protein, and the 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical-scavenging activity was measured. Alcalase hydrolysate exhibited the highest ABTS radical-scavenging activity, leading to the selection of Alcalase for further purification. The CHAO-1-I fraction, with the highest ABTS activity, was isolated and further purified, resulting in the identification of the peptide CP with the amino acid sequence Ala-Gln-Val-Met-Lys-Leu-Pro-His-Arg-Met-Gln-His-Ser-Gln-Ser. CP demonstrated antimicrobial activity against Staphylococcus aureus, inhibiting its growth. In a 2,4-dinitrochlorobenzene (DNCB)-induced AD-like skin model in mice, CP significantly alleviated skin lesions, reduced epidermal and dermal thickness, and inhibited mast cell infiltration. Moreover, CP suppressed the elevated levels of interleukin-6 (IL-6) in the plasma of DNCB-induced mice. These findings highlight the potential of CP as a therapeutic agent for AD and suggest a novel application of this C. notata by-product in the fish processing industry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Laboratory Science, College of Health Science, Dankook University, Cheonan-si 31116, Chungcheongnam-do, Republic of Korea.
Förderung
- Ministry of Oceans and Fisheries
- Ministry of Oceans and Fisheries, Korea
Zitieren
APA
Hwang, J. W., Lee, S. G., & Kang, H. (2024). Antioxidant, Antibacterial Properties of Novel Peptide CP by Enzymatic Hydrolysis of Chromis notata By-Products and Its Efficacy on Atopic Dermatitis. Marine Drugs, 22(1), 44. https://doi.org/10.3390/md22010044
Vancouver
Hwang JW, Lee SG, Kang H. Antioxidant, Antibacterial Properties of Novel Peptide CP by Enzymatic Hydrolysis of Chromis notata By-Products and Its Efficacy on Atopic Dermatitis. Marine Drugs. 2024;22(1):44. doi:10.3390/md22010044
BibTeX
@article{Hwang2024,
author = {Hwang, Jin-Woo and Lee, Sung-Gyu and Kang, Hyun},
title = {Antioxidant, Antibacterial Properties of Novel Peptide CP by Enzymatic Hydrolysis of Chromis notata By-Products and Its Efficacy on Atopic Dermatitis},
journal = {Marine Drugs},
year = {2024},
volume = {22},
number = {1},
pages = {44},
doi = {10.3390/md22010044}
}
EUVIMED